Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

January 2019 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In January 2019, FDA received 118,985 drug adverse event reports. In January 2018, FDA received 130,911.

In January 2019, FDA received 88,126 medical device reports. In January 2018, FDA received 76,781.

By drug reports received, January 2019 was number 7 of the 12 months of 2019. FDA received 119,010 drug reports a month on average in the 12 months before January 2019.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to January 2019
0100,000200,000201720182019

Drugs in the reports

The table has the 142 drug pages with 250 or more reports in January 2019. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of January 2019 name as a suspect product, in order of name
DrugReports in the month
Acetaminophen678
Acetylsalicylic Acid391
Actemra388
Afinitor261
Aimovig1,266
Alcohol737
Alprazolam1,024
Ambrisentan583
Amitriptyline283
Amlodipine613
Amoxicillin515
Ampyra5,763
Aspirin283
Atorvastatin290
Aubagio406
Avonex579
Azithromycin Anhydrous264
Benicar251
Bupropion574
Bupropion hydrochloride262
Cabometyx1,220
Capecitabine360
Carboplatin478
Ciprofloxacin274
Cisplatin287
Citalopram339
Clonazepam486
Clopidogrel264
Clozapine282
Clozaril289
Cocaine342
Codeine275
Copaxone354
Cosentyx1,706
Cyclophosphamide792
Cytarabine301
Dalfampridine413
Dexamethasone793
Diazepam583
Diphenhydramine374
Docetaxel574
Duodopa261
Dupixent721
Eliquis954
Enbrel2,293
Entresto1,028
Etoposide410
Eylea1,180
Fentanyl888
Fentanyl citrate254
Fluorouracil326
Fluoxetine281
Forteo340
Furosemide392
Gabapentin1,039
Gilenya979
Heroin360
Hetlioz337
Humalog410
Humira2,481
Ibrance644
Ibuprofen728
Imbruvica352
Ingrezza297
Insulin glargine555
Jakafi347
Lamotrigine336
Leflunomide284
Levetiracetam315
Levofloxacin266
Lisinopril366
Lorazepam401
Lyrica909
Mavyret325
Metformin633
Metformin hydrochloride317
Methadone259
Methadone hydrochloride259
Methamphetamine278
Methotrexate1,281
Methotrexate sodium773
Methylprednisolone338
Metoprolol291
MiraLAX278
Mirena521
Morphine323
Morphine sulfate537
Mycophenolate mofetil1,269
Neulasta409
Nexium520
Nexplanon382
Nivolumab495
Ocrevus375
Olanzapine365
Omeprazole417
Opdivo517
Opsumit499
Orencia616
Otezla1,398
Oxaliplatin313
Oxycodone557
Paclitaxel262
Pantoprazole390
Paracetamol446
ParaGard T 380A3,037
Pomalyst671
Pradaxa338
Praluent363
Prednisolone604
Prednisone1,146
Prolia446
Quetiapine584
Ramipril321
Remicade646
Remodulin333
Repatha576
Restasis1,696
Revlimid2,029
Risperidone257
Rituxan1,109
Rituximab834
Sertraline355
Simponi458
Soliris653
Stelara731
Sulfasalazine261
Tacrolimus818
Taltz401
Taxotere385
Tecfidera1,453
Tramadol437
Trulicity661
Tysabri732
Venclexta258
Venlafaxine280
Ventolin Hfa267
Viibryd327
Vincristine322
Xarelto805
Xeljanz1,517
Xyrem510
Zolpidem275

Reaction terms in the reports

The table has the 129 reaction terms with 500 or more reports in January 2019. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of January 2019 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort1,025
Abdominal painstomach or belly pain1,248
Abdominal pain upperupper stomach pain1,046
Abortion spontaneousmiscarriage665
Accidental exposure to product909
Acute kidney injurysudden loss of kidney function1,271
Adverse drug reactiona harmful or unpleasant reaction (the term names a medicine)584
Adverse eventan unwanted medical event, type not specified531
Alopeciahair loss1,563
Anaemialow red blood cells923
Anxietyanxiety1,338
Arthralgiajoint pain1,808
Astheniaweakness or lack of energy2,170
Atrial fibrillationan irregular heart rhythm520
Back painback pain1,216
Balance disorderproblems with balance776
Blood glucose increasedraised blood sugar reading1,019
Blood pressure increaseda raised blood pressure reading793
Bronchitischest infection525
Cardiac arrestthe heart stopped647
Cardio-respiratory arrestthe heart and breathing stopped554
Cerebrovascular accidentstroke601
Chest painchest pain931
Chillschills or shivering525
Chronic kidney diseaselong-term kidney disease655
Completed suicidedeath by suicide2,304
Complication of device insertion590
Condition aggravatedthe condition being treated got worse2,028
Confusional stateconfusion849
Constipationconstipation1,195
Coughcough1,679
Deaththe patient died; cause not stated by this term5,385
Decreased appetitereduced appetite1,206
Dehydrationdehydration606
Depressionlow mood1,266
Device dislocationthe device moved out of position861
Device expulsionthe device came out1,289
Device issuea problem with the device671
Diarrhoealoose or frequent stools3,557
Dizzinesslight-headedness or unsteadiness2,617
Drug abusemisuse of a medicine1,641
Drug effect incomplete622
Drug hypersensitivityan allergic-type reaction (the term names a medicine)2,488
Drug ineffectivethe medicine did not work as expected7,920
Drug interactionan interaction between medicines926
Drug intolerancethe medicine was not tolerated653
Dysphagiadifficulty swallowing522
Dyspnoeashortness of breath3,149
Erythemaskin redness841
Exposure during pregnancythe medicine was taken during pregnancy523
Falla fall2,334
Fatiguetiredness4,592
Feeling abnormalfeeling odd or not right1,386
Flushingsudden reddening or warmth of the skin617
Gait disturbancedifficulty walking1,721
Headachehead pain3,485
Hospitalisationadmission to hospital826
Hyperhidrosisexcessive sweating548
Hypersensitivityan allergic-type reaction996
Hypertensionhigh blood pressure1,038
Hypoaesthesianumbness890
Hypotensionlow blood pressure1,034
Inappropriate schedule of product administrationthe product was taken at the wrong times1,355
Incorrect dose administeredthe wrong dose was given1,142
Infectionan infection, type not specified811
Influenzaflu973
Injection site painpain where the injection was given935
Insomniadifficulty sleeping1,594
Intentional overdosea deliberate overdose598
Intentional product misusedeliberate use not as intended812
Intentional product use issuedeliberate use not as intended870
Loss of consciousnesspassing out628
Loss of personal independence in daily activities536
Malaisegeneral feeling of being unwell2,999
Malignant neoplasm progression629
Maternal exposure during pregnancythe mother took the medicine during pregnancy967
Memory impairmentmemory problems912
Migrainemigraine583
Mobility decreasedreduced ability to move about544
Multiple sclerosis506
Multiple sclerosis relapsea flare of multiple sclerosis665
Muscle spasmsmuscle cramps1,131
Muscular weaknessmuscle weakness693
Myalgiamuscle pain805
Myocardial infarctionheart attack506
Nasopharyngitisa cold1,650
Nauseafeeling sick4,030
Neuropathy peripheralnerve damage in hands or feet564
Neutropenialow neutrophils, a type of white blood cell657
No adverse eventno adverse event was reported937
Off label useused for a purpose or in a way not on the label4,256
Oropharyngeal painsore throat553
Overdosea dose above the recommended amount709
Painpain, site not specified2,856
Pain in extremitypain in an arm or leg1,511
Palpitationsawareness of the heartbeat556
Paraesthesiatingling or pins and needles889
Peripheral swellingswelling of the arms or legs907
Pneumonialung infection2,051
Product container issuea problem with the container638
Product dose omissiona dose was missed3,394
Product quality issuea problem with the product itself687
Product substitution issuea problem after switching products504
Product use in unapproved indicationused for a purpose not on the label2,048
Product use issuea problem in how the product was used999
Pruritusitching1,799
Psoriasispsoriasis, a skin condition656
Pyrexiafever1,746
Rashskin rash1,966
Renal failurekidney failure753
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease560
Seizurea fit or convulsion775
Sepsisa severe body-wide response to infection604
Sinusitissinus infection658
Somnolencedrowsiness1,151
Syncopefainting548
Therapy cessation1,438
Thrombocytopenialow platelets577
Toxicity to various agentspoisoning or toxic effect of one or more substances2,050
Tremorshaking868
Urinary tract infectionbladder or urinary infection1,092
Urticariahives903
Vision blurredblurred vision769
Visual impairmentreduced vision819
Vomitingbeing sick2,434
Weight decreasedweight loss1,403
Weight increasedweight gain938
White blood cell count decreasedlow white cell count561
Wrong technique in product usage processthe product was used in the wrong way1,512

Devices in the reports

The table has the 89 device pages with 100 or more reports in January 2019. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of January 2019 name, in order of name
Brand nameReports in the month
50cm Implant Lead Kit Slim Tip103
530G Insulin Pump MMT-751LNAS171
530g Insulin Pump Mmt-751nas172
630G Insulin PUMP MMT-1715K 630G BLACK MG970
640G Insulin Pump MMT-1711K1,330
640G Insulin Pump MMT-1712K1,468
Accu-Chek Spirit Combo152
Activa216
Alaris Pump Module Administration Set149
AMS 800 Urinary Control System223
AMS Inflatable Penile Prosthesis199
AMS Inflatable Penile Prosthesis with Inhibizone115
Animas Vibe684
Arctic Sun 5000112
Attain Performa101
Capsurefix Novus720
Coaguchek Xs System269
Confirm115
Dexcom G4 Platinum Continuous Glucose Monitoring System299
Dexcom G5 Mobile Continuous Glucose Monitoring System6,228
Dexcom G6 Continuous Glucose Monitoring System7,827
Dexcom G6 Mobile Continuous Glucose Monitoring System166
Durata Sts Optim Active Fixation Df-4 Connector198
Endo GIA370
Endo GIA Ultra255
Energen Icd103
Eon Mini IPG, 16-Channel Rechargeable133
Essure589
Evolut R Transcatheter Aortic Valve113
FreeStyle Freedom Lite149
FreeStyle Libre225
FreeStyle Lite137
FreeStyle Precision Neo243
Harmonic Ace 36cm W Erg Handle144
Heart Start XL164
HeartMate 3 Left Ventricular Assist System150
Heartstart Mrx246
HeartStart MRx -EMS Defibrillator183
HeartStart XL+ Defibrillator/Monitor202
HeartWare Ventricular Assist System - Pump157
Implantable Collamer Lens Icl152
Ingevity Mri218
Intellis269
Liberty Cycler Set Single Conn /Ext Dl157
Liberty Select Cycler Assy Non-Valuated296
LifeVest WCD 4000 System677
MENTOR Smooth Round Moderate Profile153
MMT-712 PARADIGM Insulin Pump133
Natura1,058
Ni322
Octrode Lead Kit, 60cm Length348
Omnipod Insulin Management System156
OmniPod Insulin Pump682
Paradigm Real-Time Revel Insulin Infusion Pump190
Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723LNAS211
Paradigm Real-Time Revel Insulin Infusion Pump Mmt-723nas148
Perclose Proglide 6f Suture Mediated Closure Smc System274
Precision Xtra118
Proclaim 5 Elite183
Proclaim 7 Elite132
Pump Mmt-1714k 630g Black Mmol Canada155
Pump Mmt-1715km 630g 3ml Black Medi248
Pump Mmt-1780k 670g 3ml Black185
Pump MMT-1780KPK 670G Pathway Black MG2,644
Quadra Assura MP ICD141
Quick-Set Paradigm165
Reservoir 3ML MMT-332A175
Resolute Onyx Rx155
Reveal LINQ207
Sensor Enlite Mmt-7008a137
Sensor Mmt-7020a Enlite3 5pk Us193
Spectrum Infusion Pump344
Sprint Quattro Secure202
Sprint Quattro Secure S236
Style 68 Saline Filled Breast Implant374
SureScan344
Synergy141
T Slim G5 System990
t:slim G4 system315
t:slim Insulin Delivery System145
t:slim X2 Insulin Pump291
t:slim X2 Insulin Pump with Basal-IQ Technology987
Teligen134
Tendril St141
Tendril Sts278
Trilogy 100153
U By Kotex Click175
U By Kotex Sleek371
V60 Ventilator566

Cite this page

Reported Reactions. January 2019: adverse event reports received by FDA. https://reportedreactions.com/month/2019-01/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for January 2019 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 118,985 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.